Sharkey, Howes & Javer’s Gilead Sciences GILD Stock Holding History

Sharkey, Howes & Javer’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-218	Closed	-$16K	–	252
2016 Q4	$16K	Hold	218	–	–	0.01%	152
2016 Q3	$17K	Hold	218	–	–	0.01%	140
2016 Q2	$18K	Sell	218 -217	-50%	-$19.3K	0.01%	143
2016 Q1	$40K	Hold	435	–	–	0.03%	102
2015 Q4	$44K	Hold	435	–	–	0.03%	103
2015 Q3	$48K	Hold	435	–	–	0.04%	90
2015 Q2	$51K	Hold	435	–	–	0.04%	71
2015 Q1	$43K	Buy	+435	New	+$44.2K	0.03%	101

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Sharkey, Howes & Javer's GILD Position: Q1 2017 in Review

Sharkey, Howes & Javer sold out of Gilead Sciences (GILD) in Q1 2017, closing a stake of 218 shares — an estimated $16K sold.

Sharkey, Howes & Javer first reported a position in GILD in Q1 2015 and held it in 8 quarters. The position peaked at $51K in Q2 2015. 1,526 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

Sharkey, Howes & Javer reported no remaining Gilead Sciences position as of Q1 2017 after selling out during the quarter.
Sharkey, Howes & Javer sold 218 Gilead Sciences shares in Q1 2017, an estimated $16K.
Sharkey, Howes & Javer first reported a position in Gilead Sciences in Q1 2015 and held it in 8 quarters.
Sharkey, Howes & Javer's Gilead Sciences position peaked at $51K in Q2 2015.
1,526 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on Sharkey, Howes & Javer's 13F filing for Q1 2017, filed 10 May 2017.